Longitudinal Ultrasound Evaluation of Carotid Atherosclerosis in One, Two and Three Dimensions

Ultrasound in Medicine and Biology

Volumn 35, Issue 3, 2009, Pages 367-375

  Mallett, Christiane ^a,b   House, Andrew A ^b   Spence, J David ^a   Fenster, Aaron ^a,b   Parraga, Grace ^a,b  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Carotid artery; Diabetes; Nephropathy; Ultrasound

Indexed keywords

CAROTID ARTERY; COMMON CAROTID ARTERIES; DIABETES; DIABETIC NEPHROPATHY; DISEASE PROGRESSIONS; INTERNAL CAROTID ARTERIES; INTIMA-MEDIA THICKNESS; LONGITUDINAL STUDIES; NEPHROPATHY; RATE OF CHANGES; SENSITIVITY AND SPECIFICITIES; SHORT PERIODS; THREE-DIMENSIONAL ULTRASOUNDS; TREATMENT GROUPS; ULTRASOUND; ULTRASOUND MEASUREMENTS; VESSEL WALLS;

ACOUSTIC WAVES; HEMODYNAMICS; INDEPENDENT COMPONENT ANALYSIS; LUMINESCENCE OF ORGANIC SOLIDS; SUGAR (SUCROSE); THREE DIMENSIONAL; ULTRASONIC DELAY LINES; ULTRASONIC TRANSMISSION; ULTRASONICS;

QUALITY CONTROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; B SCAN; CAROTID ARTERY; COMMON CAROTID ARTERY; DIABETIC NEPHROPATHY; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; INTERNAL CAROTID ARTERY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; THREE DIMENSIONAL IMAGING;

AGED; CAROTID ARTERY DISEASES; CAROTID ARTERY, COMMON; CAROTID ARTERY, INTERNAL; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; TUNICA INTIMA; TUNICA MEDIA; VITAMIN B 12; VITAMIN B 6;

EID: 60249085511     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2008.09.008     Document Type: Article

References (29)

1. Al Shali K., House A.A., Hanley A.J.G., Khan H.M.R., Harris S.B., Mamakeesick M., Zinman B., Fenster A., Spence J.D., and Hegele R.A. Differences between carotid wall morphological phenotypes measured by ultrasound in one, two and three dimensions atherosclerosis 178 (2005) 319-325
2. Barnett P.A., Spence J.D., Manuck S.B., and Jennings J.R. Psychological stress and the progression of carotid artery disease. J Hypertens 15 (1997) 49-55
3. Barter P.J., Caulfield M., Eriksson M., Grundy S.M., Kastelein J.J.P., Komajda M., Lopez-Sendon J., Mosca L., Tardif J.C., Waters D.D., Shear C.L., Revkin J.H., Buhr K.A., Fisher M.R., Tall A.R., and Brewer B. The effects of Torcetrapib in patients at high risk for coronary events. N Engl J Med 357 (2007) 2109-2122
4. Bots M.L., Evans G.W., Riley W.A., and Grobbee D.E. Carotid intima-media thickness measurements in intervention studies: Design options, progression rates, and sample size considerations: A point of view stroke 34 (2003) 2985-2994
5. Bots M.L., Visseren F.L., Evans G.W., Riley W.A., Revkin J.H., Tegeler C.H., Shear C.L., Duggan W.T., Vicari R.M., Grobbee D.E., and Kastelein J.J. Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 Study): A randomised, double-blind trial. Lancet 370 (2007) 153-160
6. Davies L., Wilmshurst E.G., McElduff A., Gunton J., Clifton-Bligh P., and Fulcher G.R. The relationship among homocysteine, creatinine clearance, and albuminuria in patients with type 2 diabetes. Diabetes Care 24 (2001) 1805-1809
7. Desbien A.M., Chonchol M., Gnahn H., and Sander D. Kidney Function and Progression of Carotid Intima-Media Thickness in a Community Study. Am J Kidney Dis 51 (2008) 584-593
8. Egger M., Chiu B., Spence J.D., Fenster A., and Parraga G. Mapping spatial and temporal changes in carotid atherosclerosis from three-dimensional ultrasound images. Ultrasound Med Biol 34 (2008) 64-72
9. Egger M., Krasinski A., Rutt B.K., Fenster A., and Parraga G. Comparison of B-mode ultrasound, three-dimensional ultrasound and magnetic resonance imaging measurements of carotid atherosclerosis. J Ultrasound Med (2008) (in press)
10. Egger M., Spence J.D., Fenster A., and Parraga G. Validation of 3D ultrasound vessel wall volume: An imaging phenotype of carotid atherosclerosis. Ultrasound Med Biol 33 (2007) 905-914
11. Graham I.M., Daly L.E., Refsum H.M., Robinson K., Brattstrom L.E., Ueland P.M., Palma-Reis R.J., Boers G.H., Sheahan R.G., Israelsson B., Uiterwaal C.S., Meleady R., McMaster D., Verhoef P., Witteman J., Rubba P., Bellet H., Wautrecht J.C., de Valk H.W., Sales Luis A.C., Parrot-Rouland F.M., Tan K.S., Higgins I., Garcon D., Andria G., et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 277 (1997) 1775-1781
12. Hackam D.G., Peterson J.C., and Spence J.D. What level of plasma homocyst(e)ine should be treated?. Effects of vitamin therapy on progressions of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14 Umol/Lc. Am J Hypertens 13 (2000) 105-110
13. Hedblad B., Zambanini A., Nilsson P., Janzon L., and Berglund G. Rosiglitazone and carotid IMT progression rate in a mixed cohort of patients with type 2 diabetes and the insulin resistance syndrome: Main results from the rosiglitazone atherosclerosis study. J Intern Med 261 (2007) 293-305
14. Johnsen S.H., Mathiesen E.B., Joakimsen O., Stensland E., Wilsgaard T., Lochen M.L., Njolstad I., and Arnesen E. Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: A 6-year follow-up study of 6226 persons: The Tromso Study. Stroke 38 (2007) 2873-2880
15. Kastelein J.J.P., Akdim F., Stroes E.S.G., Zwinderman A.H., Bots M.L., Stalenhoef A.F.H., Visseren F.L.J., Sijbrands E.J.G., Trip M.D., Stein E.A., Gaudet D., Duivenvoorden R., Veltri E.P., Marais A.D., and de Groot E. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 358 (2008) 1431-1443
16. Kastelein J.J.P., Sager P.T., de Groot E., and Veltri E. Comparison of ezetimibe plus simvastatin versus simvastatin monotherapy on atherosclerosis progression in familial hypercholesterolemia: Design and rationale of the ezetimibe and simvastatin in hypercholesterolemia enhances atherosclerosis regression (ENHANCE) trial. Am Heart J 149 (2005) 234-239
17. Kastelein J.J.P., van Leuven S.I., Burgess L., Evans G.W., Kuivenhoven J.A., Barter P.J., Revkin J.H., Grobbee D.E., Riley W.A., Shear C.L., Duggan W.T., and Bots M.L. Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia. N Engl J Med 356 (2007) 1620-1630
18. Landry A., Spence J.D., and Fenster A. Measurement of carotid plaque volume by three-dimensional ultrasound. Stroke 35 (2004) 864-869
19. Landry A., Spence J.D., and Fenster A. Quantification of carotid plaque volume measurements using 3D ultrasound imaging. Ultrasound Med Biol 31 (2005) 751-762
20. Neugebauer S., Baba T., Kurokawa K., and Watanabe T. Defective homocysteine metabolism as a risk factor for diabetic retinopathy. Lancet 349 (1997) 473-474
21. Nygard O., Nordrehaug J.E., Refsum H., Ueland P.M., Farstad M., and Vollset S.E. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337 (1997) 230-237
22. Parving H.H., Rossing P., Hommel E., and Smidt U.M. Angiotensin-converting enzyme inhibition in diabetic nephropathy: Ten years' experience. Am J Kidney Dis 26 (1995) 99-107
23. Pignoli P., Tremoli E., Poli A., Oreste P., and Paoletti R. Intimal plus medial thickness of the arterial wall: A direct measurement with ultrasound imaging. Circulation 74 (1986) 1399-1406
24. Schulte-Altedorneburg G., Droste D.W., Felszeghy S., Kellermann M., Popa V., Hegedus K., Hegedus C., Schmid M., Modis L., Ringelstein E.B., and Csiba L. Accuracy of in vivo carotid B-mode ultrasound compared with pathological analysis: Intima-media thickening, lumen diameter, and cross-sectional area. Stroke 32 (2001) 1520-1524
25. Selzer R.H., Hodis H.N., Kwong-Fu H., Mack W.J., Lee P.L., Liu C., and Liu Ch. Evaluation of computerized edge tracking for quantifying intima-media thickness of the common carotid artery from B-mode ultrasound images. Atherosclerosis 111 (1994) 1-11
26. Spence J.D. Ultrasound measurement of carotid plaque as a surrogate outcome for coronary artery disease. Am J Cardiol 89 (2002) 10-15
27. Spence J.D., Eliasziw M., DiCicco M., Hackam D.G., Galil R., and Lohmann T. Carotid plaque area: A tool for targeting and evaluating vascular preventive therapy. Stroke 33 (2002) 2916-2922
28. Vaccaro O., Ingrosso D., Rivellese A., Greco G., and Riccardi G. Moderate hyperhomocysteinaemia and retinopathy in insulin-dependent diabetes. Lancet 349 (1997) 1102-1103
29. Wong M., Edelstein J., Wollman J., and Bond M.G. Ultrasonic-pathological comparison of the human arterial wall: Verification of intima-media thickness. Arterioscler Thromb 13 (1993) 482-486